Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early-TMS in Major Depression
NCT06545474Not yet recruiting
- Sponsor
- University Hospital Tübingen
- Start
- Sep 2024
- Primary completion
- Dec 2026
01
Overview
Randomised, open-label trial (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Response rates after Stage I at 4 weeks. Planned start Sep 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06545474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06545474.